Scientists have uncovered a surprising mechanism by which a brain enzyme called OTULIN controls the expression of tau, the ...
Independent.ie on MSN
Ozempic pill fails to slow Alzheimer’s in new studies
A pill version of Novo Nordisk’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of high-risk studies that aimed to open up a new use for blockbuster obesity drugs. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback